- Home
- BAK vs BCRX Comparison
BAK vs BCRX Comparison
Compare BAK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAK
- BCRX
- Stock Information
- Founded
- BAK 1972
- BCRX 1986
- Country
- BAK Brazil
- BCRX United States
- Employees
- BAK N/A
- BCRX N/A
- Industry
- BAK Major Chemicals
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BAK Industrials
- BCRX Health Care
- Exchange
- BAK Nasdaq
- BCRX Nasdaq
- Market Cap
- BAK 1.4B
- BCRX 1.7B
- IPO Year
- BAK N/A
- BCRX 1994
- Fundamental
- Price
- BAK $3.56
- BCRX $10.09
- Analyst Decision
- BAK Strong Buy
- BCRX Buy
- Analyst Count
- BAK 3
- BCRX 8
- Target Price
- BAK $9.75
- BCRX $16.75
- AVG Volume (30 Days)
- BAK 1.1M
- BCRX 3.7M
- Earning Date
- BAK 08-06-2025
- BCRX 08-04-2025
- Dividend Yield
- BAK N/A
- BCRX N/A
- EPS Growth
- BAK N/A
- BCRX N/A
- EPS
- BAK N/A
- BCRX N/A
- Revenue
- BAK $13,770,122,923.00
- BCRX $503,485,000.00
- Revenue This Year
- BAK $18.11
- BCRX $39.04
- Revenue Next Year
- BAK $7.32
- BCRX $13.26
- P/E Ratio
- BAK N/A
- BCRX N/A
- Revenue Growth
- BAK 14.35
- BCRX 41.67
- 52 Week Low
- BAK $2.85
- BCRX $5.92
- 52 Week High
- BAK $7.71
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- BAK 45.20
- BCRX 43.54
- Support Level
- BAK $3.62
- BCRX $9.84
- Resistance Level
- BAK $3.87
- BCRX $10.47
- Average True Range (ATR)
- BAK 0.13
- BCRX 0.34
- MACD
- BAK -0.02
- BCRX -0.19
- Stochastic Oscillator
- BAK 11.46
- BCRX 8.16
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.